Dimensioni, segmenti e analisi del mercato delle terapie per i disturbi neurologici entro il 2025-2031
Neurologic Disorders Therapeutics Market Report Analysis
Neurologic Disorders Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Biogen Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Novartis AG
- Pfizer Inc.
- Sage Therapeutics, Inc
- Boehringer Ingelheim International GmbH
- Bayer AG
- GlaxoSmithKline plc
Regional Overview
- Nord America
- Europa
- Asia-Pacifico
- America centrale e meridionale
- Medio Oriente e Africa
Market Segmentation
By Indicazione
- malattia di Parkinson
- malattia di Alzheimer
- disturbi psicotici
- disturbi epilettici
- disturbi di autismo
- malattie tumorali al cervello
By Classe del farmaco
- ACE inibitori
- antagonisti NMDA
- antagonisti D2
- altri
By Applicazione [Sistema nervoso centrale
- SNC
- sistema nervoso periferico
By Geografia
- America del Nord
- Europa
- Asia-Pacifico
- America centrale e meridionale
Get Free Sample For